Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

Murat Beyazyüz,1 Tarkan Küfeciler,2 Leyla Bulut,3 Cüneyt Ünsal,1 Yakup Albayrak,1 Esra Soydaş Akyol,4 Saliha Baykal,1 Murat Kuloglu,5 Kenji Hashimoto61Department of Psychiatry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey; 2Department of Emergency...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/373cdc0d13944cff8656b13517040848
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:373cdc0d13944cff8656b13517040848
record_format dspace
spelling oai:doaj.org-article:373cdc0d13944cff8656b135170408482021-12-02T01:55:35ZIncreased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study1178-2021https://doaj.org/article/373cdc0d13944cff8656b135170408482016-05-01T00:00:00Zhttps://www.dovepress.com/increased-serum-levels-of-apoptosis-in-deficit-syndrome-schizophrenia--peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Murat Beyazyüz,1 Tarkan Küfeciler,2 Leyla Bulut,3 Cüneyt Ünsal,1 Yakup Albayrak,1 Esra Soydaş Akyol,4 Saliha Baykal,1 Murat Kuloglu,5 Kenji Hashimoto61Department of Psychiatry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey; 2Department of Emergency Medicine, Çekirge State Hospital, Bursa, Turkey; 3Department of Biochemistry, Okmeydani Education and Research Hospital, Istanbul, Turkey; 4Department of Psychiatry, Yenimahalle Education and Research Hospital, Ankara, Turkey; 5Department of Psychiatry, Faculty of Medicine, Akdeniz University, Antalya, Turkey; 6Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, JapanBackground: Schizophrenia is a chronic and debilitating disorder, the etiology of which remains unclear. Apoptosis is a programmed cell death mechanism that might be implicated in neuropsychiatric disorders, including schizophrenia. In this study, we aimed to compare the serum levels of apoptosis among deficit schizophrenia (DS) syndrome patients, nondeficit schizophrenia (NDS) patients, and healthy controls (HCs).Patients and methods: After the inclusion and exclusion criteria were applied, 23 DS patients, 46 NDS patients, and 33 HCs were included in the study. The serum apoptosis levels were measured using a quantitative sandwich enzyme immunoassay with human monoclonal antibodies directed against DNA and histones.Results: There was a significant difference among the three groups in terms of the levels of apoptosis (F2,96=16.58; P<0.001). The serum apoptosis levels in the DS and NDS groups were significantly higher than those in the HC group. Furthermore, the serum apoptosis levels in the DS group were significantly higher than the levels in the NDS group.Conclusion: This study suggests that increased levels of apoptosis may be implicated in the pathophysiology of DS syndrome. However, further studies are needed to support the role of apoptosis in DS.Keywords: apoptosis, etiology, deficit, psychosisBeyazyüz MKüfeciler TBulut LÜnsal CAlbayrak YAkyol ESBaykal SKuloglu MHashimoto KDove Medical PressarticleApoptosisDeficit syndromeSchizophreniaNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 1261-1268 (2016)
institution DOAJ
collection DOAJ
language EN
topic Apoptosis
Deficit syndrome
Schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Apoptosis
Deficit syndrome
Schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Beyazyüz M
Küfeciler T
Bulut L
Ünsal C
Albayrak Y
Akyol ES
Baykal S
Kuloglu M
Hashimoto K
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
description Murat Beyazyüz,1 Tarkan Küfeciler,2 Leyla Bulut,3 Cüneyt Ünsal,1 Yakup Albayrak,1 Esra Soydaş Akyol,4 Saliha Baykal,1 Murat Kuloglu,5 Kenji Hashimoto61Department of Psychiatry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey; 2Department of Emergency Medicine, Çekirge State Hospital, Bursa, Turkey; 3Department of Biochemistry, Okmeydani Education and Research Hospital, Istanbul, Turkey; 4Department of Psychiatry, Yenimahalle Education and Research Hospital, Ankara, Turkey; 5Department of Psychiatry, Faculty of Medicine, Akdeniz University, Antalya, Turkey; 6Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, JapanBackground: Schizophrenia is a chronic and debilitating disorder, the etiology of which remains unclear. Apoptosis is a programmed cell death mechanism that might be implicated in neuropsychiatric disorders, including schizophrenia. In this study, we aimed to compare the serum levels of apoptosis among deficit schizophrenia (DS) syndrome patients, nondeficit schizophrenia (NDS) patients, and healthy controls (HCs).Patients and methods: After the inclusion and exclusion criteria were applied, 23 DS patients, 46 NDS patients, and 33 HCs were included in the study. The serum apoptosis levels were measured using a quantitative sandwich enzyme immunoassay with human monoclonal antibodies directed against DNA and histones.Results: There was a significant difference among the three groups in terms of the levels of apoptosis (F2,96=16.58; P<0.001). The serum apoptosis levels in the DS and NDS groups were significantly higher than those in the HC group. Furthermore, the serum apoptosis levels in the DS group were significantly higher than the levels in the NDS group.Conclusion: This study suggests that increased levels of apoptosis may be implicated in the pathophysiology of DS syndrome. However, further studies are needed to support the role of apoptosis in DS.Keywords: apoptosis, etiology, deficit, psychosis
format article
author Beyazyüz M
Küfeciler T
Bulut L
Ünsal C
Albayrak Y
Akyol ES
Baykal S
Kuloglu M
Hashimoto K
author_facet Beyazyüz M
Küfeciler T
Bulut L
Ünsal C
Albayrak Y
Akyol ES
Baykal S
Kuloglu M
Hashimoto K
author_sort Beyazyüz M
title Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
title_short Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
title_full Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
title_fullStr Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
title_full_unstemmed Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
title_sort increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/373cdc0d13944cff8656b13517040848
work_keys_str_mv AT beyazyuumlzm increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT kuumlfecilert increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT bulutl increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT uumlnsalc increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT albayraky increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT akyoles increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT baykals increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT kuloglum increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
AT hashimotok increasedserumlevelsofapoptosisindeficitsyndromeschizophreniapatientsapreliminarystudy
_version_ 1718402767361409024